September 21, 2012 / 12:15 PM / 5 years ago

BRIEF-ViroPharma jumps in premarket after FDA lifts hold on Cinryze testing

NEW YORK, Sept 21 (Reuters) - ViroPharma Inc : * Jumps 6.5 percent to $30 in premarket after FDA lifts hold on Cinryze testing

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below